Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Restrictions On Rx Acetaminophen Show How Practical Concerns Influence Safety Actions

This article was originally published in The Pink Sheet Daily

Executive Summary

Because the agency can move faster on Rx products than OTCs, non-prescription products will have higher acetaminophen levels than Rx drugs, at least for the time being.
Advertisement

Related Content

FDA’s Rx Acetaminophen Safety Program Ramps Up Enforcement
Actavis’ MoxDuo: Can A Generic Firm Drive Growth With A Low-Dose Product?
Pressure Builds For Revamped Acetaminophen Warnings In Rx Dispensing Materials
Pressure Builds For Revamped Acetaminophen Warnings In Rx Dispensing Materials
One Acetaminophen Headache Remains Untreated: Acronyms On Pharmacy Containers
One Acetaminophen Headache Remains Untreated: Acronyms On Pharmacy Containers
Propoxyphene Marketing Halted By FDAAA-Required QT Safety Study
Acetaminophen May Get Pulled From Rx Combo Products After Narrow Vote
Acetaminophen May Get Pulled From Rx Combo Products After Narrow Vote

Topics

Advertisement
UsernamePublicRestriction

Register

PS071690

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel